JEFFS ROGER 1231615 Data last updated 2024-05-14 07:02:16 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-18 | 2023-12-14 | 2023-12-14 | 4 | Jeffs Roger | CEO | acq | 139665.0 | 21.8 | 21.52 | 7.16 | Direct | Common Stock | LIQUIDIA CORP | code P | 640805.0 | 64.91 (LQDA) |
| 2023-12-18 | 2023-12-14 | 4 | Jeffs Roger | CEO | holding | 46595.0 | 0 | 7.18 | 0.0 | Roger A | Common Stock | LIQUIDIA CORP | NA | 64.91 (LQDA) | ||
| 2023-12-18 | 2023-12-14 | 4 | Jeffs Roger | CEO | holding | 1541667.0 | 0 | 237.52 | 0.0 | Serendipity Bio Pharma Llc | Common Stock | LIQUIDIA CORP | NA | 64.91 (LQDA) | ||
| 2024-01-16 | 2024-01-11 | 4 | Jeffs Roger | CEO | holding | 1541667.0 | 0 | 237.52 | 0.0 | Serendipity Bio Pharma Llc | Common Stock | LIQUIDIA CORP | NA | 64.91 (LQDA) | ||
| 2024-01-16 | 2024-01-11 | 4 | Jeffs Roger | CEO | holding | 46595.0 | 0 | 7.18 | 0.0 | Roger A | Common Stock | LIQUIDIA CORP | NA | 64.91 (LQDA) | ||
| 2024-01-16 | 2024-01-11 | 2024-01-11 | 4 | Jeffs Roger | CEO | acq | 221338.0 | 25.67 | 34.1 | 0.0 | Direct | Common Stock | LIQUIDIA CORP | code A | 862143.0 | 64.91 (LQDA) |
| 2024-03-15 | 2024-03-14 | 2024-03-14 to 2024-03-15 | 4 | Jeffs Roger | DIRECTOR | acq | 32323.0 | 26.26 | 6.83 | 24.44 | Direct | Common Stock | AXSOME THERAPEUTICS, INC. | code M | 123103.0
|
47.32 (AXSM) |
| 2024-03-15 | 2024-03-14 | 2024-03-14 to 2024-03-15 | 4 | Jeffs Roger | DIRECTOR | dsp | 32323.0 | 21.12 | 6.83 | 69.84 | Direct | Common Stock | AXSOME THERAPEUTICS, INC. | code S | 120756.0
|
47.32 (AXSM) |
| 2024-03-15 | 2024-03-14 | 4 | Jeffs Roger | DIRECTOR | holding | 46912.0 | 0 | 9.91 | 0.0 | Grat | Common Stock | AXSOME THERAPEUTICS, INC. | NA | 47.32 (AXSM) | ||
| 2024-03-19 | 2024-03-18 | 4 | Jeffs Roger | CEO | holding | 1541667.0 | 0 | 202.78 | 0.0 | Serendipity Bio Pharma Llc | Common Stock | LIQUIDIA CORP | NA | 76.03 (LQDA) | ||
| 2024-03-19 | 2024-03-18 | 4 | Jeffs Roger | CEO | holding | 46595.0 | 0 | 6.13 | 0.0 | Roger A | Common Stock | LIQUIDIA CORP | NA | 76.03 (LQDA) | ||
| 2024-03-19 | 2024-03-18 | 2024-03-18 | 4 | Jeffs Roger | CEO | dsp | 28583.0 | 3.31 | 3.76 | 15.82 | Direct | Common Stock | LIQUIDIA CORP | code S | 835345.0 | 76.03 (LQDA) |
| 2024-04-16 | 2024-04-12 | 4 | Jeffs Roger | CEO | holding | 46595.0 | 0 | 6.13 | 0.0 | Roger A | Common Stock | LIQUIDIA CORP | NA | 76.03 (LQDA) | ||
| 2024-04-16 | 2024-04-12 | 4 | Jeffs Roger | CEO | holding | 1541667.0 | 0 | 202.78 | 0.0 | Serendipity Bio Pharma Llc | Common Stock | LIQUIDIA CORP | NA | 76.03 (LQDA) | ||
| 2024-04-16 | 2024-04-12 | 2024-04-12 | 4 | Jeffs Roger | CEO | dsp | 8360.0 | 1.0 | 1.1 | 14.58 | Direct | Common Stock | LIQUIDIA CORP | code S | 826985.0 | 76.03 (LQDA) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-06 | 2023-06-02 | 2023-06-02 | 4 | Jeffs Roger | DIRECTOR | acq | 5681.0 | 100.0 | 1.3 | 74.12 | Direct | Stock Option (Right To Buy) | AXSOME THERAPEUTICS, INC. | code A | 5681.0 | 43.57 (AXSM) |
| 2024-01-16 | 2024-01-11 | 2024-01-11 | 4 | Jeffs Roger | CEO | acq | 221338.0 | 100.0 | 34.1 | 0.0 | Direct | Performance Stock Units | LIQUIDIA CORP | code A | 221338.0 | 64.91 (LQDA) |
| 2024-02-29 | 2024-02-27 | 2024-02-27 | 4 | Jeffs Roger | DIRECTOR | acq | 1425.0 | 100.0 | 0.3 | 84.0 | Direct | Stock Option (Right To Buy) | AXSOME THERAPEUTICS, INC. | code A | 1425.0 | 47.32 (AXSM) |
| 2024-03-15 | 2024-03-14 | 2024-03-14 to 2024-03-15 | 4 | Jeffs Roger | DIRECTOR | dsp | 32323.0 | 100.0 | 6.83 | 24.44 | Direct | Stock Option (Right To Buy) | AXSOME THERAPEUTICS, INC. | code M | 0.0
|
47.32 (AXSM) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)